ES2195200T3 - Construccion de peptidos de rama multiples. - Google Patents

Construccion de peptidos de rama multiples.

Info

Publication number
ES2195200T3
ES2195200T3 ES97953934T ES97953934T ES2195200T3 ES 2195200 T3 ES2195200 T3 ES 2195200T3 ES 97953934 T ES97953934 T ES 97953934T ES 97953934 T ES97953934 T ES 97953934T ES 2195200 T3 ES2195200 T3 ES 2195200T3
Authority
ES
Spain
Prior art keywords
cellular
peptides
hiv
fusion
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97953934T
Other languages
English (en)
Inventor
Kamel Mabrouk
Jean-Marc Sabatier
Herve Rochat
Rietschoten Jurphaas Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellpep SA
Original Assignee
Cellpep SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellpep SA filed Critical Cellpep SA
Application granted granted Critical
Publication of ES2195200T3 publication Critical patent/ES2195200T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNAS CONSTRUCCIONES DE PEPTIDOS DE RAMIFICACIONES MULTIPLES, FORMADAS A PARTIR DE PEPTIDOS DERIVADOS DE LA GLICOPROTEINA DE TRANSMEMBRANA QUE FORMAN UNA ENVOLTURA GP41 DEL VIH E INCLUYEN LA SECUENCIA DE CONSENSO RQGY, PRECEDIDA DE 0 A 4 RESIDUOS DE ACIDOS AMINADOS, Y SEGUIDA DE 2 A 4 RESIDUOS DE ACIDOS AMINADOS, PREFERENTEMENTE, RQGYSPL. ESTAS CONSTRUCCIONES MUESTRAN UNA AFINIDAD DE RECEPTOR INCREMENTADA E IMPIDEN LA FUSION DE UNA CELULA A OTRA. EJERCEN UN EFECTO VIROSTATICO DIRECTO. POR EL HECHO DE QUE PRESENTAN LA MISMA FRECUENCIA DE PEPTIDOS VARIAS VECES, ESTOS MBPCS PUEDEN NEUTRALIZAR IN VITRO LAS DIFERENTES ETAPAS DE FUSION DE ENVOLTURA VIRAL/MEMBRANA CELULAR, Y DE FUSION DE MEMBRANA CELULAR INFECTADA/MEMBRANA CELULAR NO INFECTADA DE VARIAS CEPAS DE VIH -1 Y VIH - 2. ESTOS RESULTADOS PERMITEN UN USO POTENCIAL EN EL TRATAMIENTO DE LA INFECCION POR VIH.
ES97953934T 1996-12-31 1997-12-30 Construccion de peptidos de rama multiples. Expired - Lifetime ES2195200T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9627114.3A GB9627114D0 (en) 1996-12-31 1996-12-31 Multiple branch peptide constructions

Publications (1)

Publication Number Publication Date
ES2195200T3 true ES2195200T3 (es) 2003-12-01

Family

ID=10805139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97953934T Expired - Lifetime ES2195200T3 (es) 1996-12-31 1997-12-30 Construccion de peptidos de rama multiples.

Country Status (12)

Country Link
US (1) US6379679B1 (es)
EP (1) EP0950063B1 (es)
AP (1) AP9901615A0 (es)
AT (1) ATE235511T1 (es)
AU (1) AU5764898A (es)
CA (1) CA2274853C (es)
DE (1) DE69720266T2 (es)
DK (1) DK0950063T3 (es)
ES (1) ES2195200T3 (es)
GB (1) GB9627114D0 (es)
PT (1) PT950063E (es)
WO (1) WO1998029443A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727424D0 (en) * 1997-12-31 1998-02-25 Armel Sa Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
US7285621B2 (en) * 1999-06-29 2007-10-23 Ambrilia Biopharma Multiple branch peptide construction
WO2004092724A2 (en) * 2003-04-11 2004-10-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
US20060229433A1 (en) * 2003-05-20 2006-10-12 Cellpep Sa Modified antiviral peptides with increased activity and cell membrane affinity
WO2008094222A2 (en) * 2006-10-06 2008-08-07 Trustees Of Princeton Porphyrin catalysts and methods of use thereof
AU2017259821A1 (en) 2016-05-04 2018-12-13 Abilita Bio, Inc. Methods and platform for preparing multispanning membrane proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
WO1993003766A1 (en) * 1991-08-13 1993-03-04 Repligen Corporation Multiple antigen peptides for use as hiv vaccines
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
IL110929A0 (en) * 1993-09-13 1994-11-28 Armel Sa Multiple branch peptide constructions and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK0950063T3 (da) 2003-06-23
US6379679B1 (en) 2002-04-30
WO1998029443A1 (en) 1998-07-09
CA2274853C (en) 2007-05-29
AU5764898A (en) 1998-07-31
AP9901615A0 (en) 1999-09-30
EP0950063B1 (en) 2003-03-26
GB9627114D0 (en) 1997-02-19
ATE235511T1 (de) 2003-04-15
EP0950063A1 (en) 1999-10-20
DE69720266T2 (de) 2003-12-04
DE69720266D1 (de) 2003-04-30
PT950063E (pt) 2003-07-31
CA2274853A1 (en) 1998-07-09

Similar Documents

Publication Publication Date Title
ATE380822T1 (de) Funf-helix protein
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
BR0210598A (pt) Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie
CO4750842A1 (es) Pox virus recombinantes de mapache y vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina .
ES2104556T3 (es) Peptidos que tienen propiedades inmunologicas de hiv-2.
EP1878742A3 (en) HIV peptides, antigens, vaccine compositions, immunoassay and a method of detecting antibodies induced by HIV
DK0891982T3 (da) HIV-peptider
EA200200724A1 (ru) Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич)
ZA200107072B (en) HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV.
DE3853779D1 (de) Hiv-1 neutralisierende monoklonale antikörper.
ES2184869T3 (es) Vacuna sub-unitaria contra la infeccion por flavivirus.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
DE3855134T2 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE148918T1 (de) Für die co4-bindende domäne von hiv spezifische antikörper
ES2195200T3 (es) Construccion de peptidos de rama multiples.
ES2115622T3 (es) Clones moleculares de hiv-1 y usos de los mismos.
ES2058100T3 (es) Vacuna combinada.
ES2191058T3 (es) Celulas portadoras de receptores simulados de cd4, y moleculas y metodos relacionados.
ES2137378T3 (es) Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv.
JP2002508338A5 (es)
ES2104695T3 (es) Induccion de proteccion contra una infeccion virica.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
ES2073287T3 (es) Metodo para el diagnostico in vitro de infecciones con virus hiv-1.
AP1561A (en) Use of non-cytolytic retrovirus as vaccines for the treatment of HIV infection.